JPRN-jRCTs041180063
Active, not recruiting
Phase 3
A randomized, double-blind study on the effect of daiobotanpito as additional option in treating acute diverticulitis - DADIDA trial
Ogawa Keiko0 sites170 target enrollmentMarch 1, 2019
Conditionsdiverticulitis
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- diverticulitis
- Sponsor
- Ogawa Keiko
- Enrollment
- 170
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants who meet the following criteria are eligible
- •(a) Moderate to severe diverticulitis
- •Diagnosis was based on the image of Computed Tomography (CT),
- •diverticulalike structure in accordance with tenderness or abdominal pain, a thickening of colon wall, signs of inflammation of the pericolonic fat, the tissue density, and vascular involvement. Pericolonic abscess, free air or extravasation, and accumulation of fluid were also noticed to predict prognosis.
- •(b)At least 20 years old and under 75 years old
- •(c)Patients who can communicate with each other
- •(d)Patients with abdominal pain and/or fever above 37\.5 degrees
- •(e)After receiving sufficient explanation for the participation of this study, after sufficient understanding, the patient's willingness to freely by written agreement to be obtained.
Exclusion Criteria
- •(a) Patients with severe dysfunction in the following organs.
- •(Blood tests are allowed within 4 weeks before treatment starts)
- •Renal function: serum creatinine value\> 1\.5 times the upper limit of institution standard
- •Liver function: serum AST value or serum ALT value\> 3 times the facility reference upper limit value
- •Central nervous function: encephalopathy or a patient suspected of it
- •Electrolyte: serum Na \<125 mEq / L, serum K \<3\.3 mEq / L
- •(b) Patients considered highly likely to have perforation of abscess due to malnutrition (Alb \<2\.5 g / dL)
- •(c) Patients with obstructive ileus symptoms
- •(d) Patients who have chronic anorexia, abdominal pain, diarrhea symptoms before the onset of coloren diverticulitis
- •(e) Before the onset of colorectal diverticulitis, Performance Status (PS), one of the indicators of the general condition and the degree of restriction of the patient's daily life, is 3 or above
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A double-blind, randomised study on the effects of STW 5 on symptoms and immunologic function in patients with irritable bowel syndromeIrritable Bowel SyndromeOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12609000085279Royal Adelaide Hospital Gastroenterology and Hepatology60
Active, not recruiting
Not Applicable
A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in children - Efficacy of cycloplegicsDepth of cycloplegiachanges of astigmatismrecuperation from cycloplegia and mydriasisMedDRA version: 12.1Level: LLTClassification code 10011719Term: CycloplegiaMedDRA version: 12.1Level: PTClassification code 10011719Term: CycloplegiaEUCTR2010-021410-34-NLMedical Centre Haaglanden423
Completed
Phase 3
A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in childreNL-OMON34025Medisch Centrum Haaglanden419
Completed
Not Applicable
Oestrogen trial to delay the onset of memory impairmentAlzheimer?s disease (AD)Nervous System DiseasesAlzheimer?s diseaseISRCTN44726453Sunnybrook and Women's College Health Sciences Centre (Canada)146
Not yet recruiting
Phase 3
Effect of the Informative Paper on patients and families in a Oncogenetic Ambulatory :evaluation of information and perception of coercion.RBR-4y59tqHospital de Clínicas de Porto Alegre